Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

NCT00280995 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia, Familial

Interventions

DRUG: ISIS 301012
DRUG: ISIS 301012
DRUG: ISIS 301012
DRUG: ISIS 301012

Sponsor

Kastle Therapeutics, LLC

Collaborators

[object Object]